John Sauret, MD
Family Medicine · Niagara Falls, NYNPI 1225000268
Payments from drug & device makers
Across 240 payments — averaging $23.16 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$1K
- GSK$929
- Exact Sciences$596
- Lilly USA, LLC$429
- Pfizer$352
- E.r. Squibb & Sons, L.L.C.$315
- plus $2K from 26 others
What the payments were for
- Food & beverage$5,558100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 19 | $1,161 |
| GSK | 55 | $929 |
| Exact Sciences | 11 | $596 |
| Lilly USA, LLC | 25 | $429 |
| Pfizer | 27 | $352 |
| E.r. Squibb & Sons, L.L.C. | 12 | $315 |
| Novo Nordisk | 15 | $254 |
| Shield Therapeutics Inc | 12 | $191 |
| Mylan Specialty L.p. | 7 | $184 |
| Insulet Corporation | 6 | $145 |
| Amgen | 7 | $129 |
| Indivior Inc. | 5 | $117 |
| Bayer | 5 | $84 |
| Gilead | 3 | $80 |
| Mannkind Corporation | 3 | $77 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 3 | $58 |
| Johnson & Johnson | 4 | $52 |
| Merck | 3 | $51 |
| Vertex | 2 | $48 |
| Abbott | 2 | $39 |
| Optinose US, Inc. | 2 | $36 |
| Boston Scientific | 1 | $35 |
| Phathom Pharmaceuticals, Inc. | 2 | $29 |
| Metacel Pharmaceuticals LLC | 1 | $27 |
| Grifols USA, LLC | 1 | $25 |
| Phadia US Inc. | 1 | $24 |
| Xeris Pharmaceuticals, Inc. | 1 | $22 |
| Vanda Pharmaceuticals Inc. | 1 | $16 |
| Sanofi-aventis U.S. LLC | 1 | $16 |
| Philips North America LLC | 1 | $15 |
| AbbVie | 1 | $13 |
| Advanced Oxygen Therapy Inc. | 1 | $9 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- BREZTRI$772
- AIRSUPRA$523
- Cologuard Collection Kit$331
- FARXIGA$231
- ELIQUIS$125
- TRELEGY ELLIPTA$121
How this compares
$5,558 in reported general payments places this provider in the 85th percentile of 4,321 family medicine providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| TrulicityDulaglutide | 74 | $96,975 |
| EliquisApixaban | 117 | $81,427 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 79 | $59,612 |
| JardianceEmpagliflozin | 44 | $40,860 |
| XareltoRivaroxaban | 29 | $27,040 |
| OzempicSemaglutide | 18 | $22,923 |
| SymbicortBudesonide/Formoterol Fumarate | 80 | $20,526 |
| TradjentaLinagliptin | 36 | $19,276 |
| Anoro ElliptaUmeclidinium Brm/Vilanterol Tr | 27 | $17,188 |
| JanuviaSitagliptin Phosphate | 18 | $16,653 |
| LinzessLinaclotide | 30 | $16,581 |
| Advair HfaFluticasone Propion/Salmeterol | 50 | $15,952 |
| Combivent RespimatIpratropium/Albuterol Sulfate | 23 | $12,043 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 16 | $11,151 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 336 | $9,549 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCTrulicity | $429 | $96,97574 claims |
| PfizerEliquis, Lyrica | $352 | $88,051128 claims |
| GSKTrelegy Ellipta, Anoro Ellipta, Breo Ellipta, Incruse Ellipta | $929 | $86,733132 claims |
| AstraZenecaSymbicort, Breztri Aerosphere | $1,161 | $31,67796 claims |
| Johnson & JohnsonXarelto | $52 | $27,04029 claims |
| Novo NordiskOzempic | $254 | $22,92318 claims |
| AbbVieLinzess, Synthroid | $13 | $20,87995 claims |
| MerckJanuvia | $51 | $16,65318 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 4,321 family medicine providers in New York.
Other family medicine in Niagara Falls
- Matthew DavisRochester$76.6M
- Frank EderBinghamton$46.2M
- Suchet PatelEndwell$23.3M
- James WildGowanda$2.2M
- Michael FedericoEndwell$1.4M
- Donald BrautigamWestfield$1.3M
- Kimberly DesantisEndwell$1.1M
- Michael TugetmanHartsdale$1M
- Richard RuhOrchard Park$769K
- Eric LorraineEndwell$740K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.